Enantiomeric Separation of (R)-5-(1-Hydroxyethyl)-2-(pyridine- 2-yl)-[1, 3, 4]-thiadiazole, an Intermediate of Nafithromycin on Immobilized Amylose Based Stationary Phase-Reference-Cited by-同舟云学术

Enantiomeric Separation of (R)-5-(1-Hydroxyethyl)-2-(pyridine- 2-yl)-[1, 3, 4]-thiadiazole, an Intermediate of Nafithromycin on Immobilized Amylose Based Stationary Phase

Published:2022-05-04 Issue:3 Volume:12 Page:409-418
ISSN:2229-7928
Container-title:Analytical Chemistry Letters
language:en
Short-container-title:Analytical Chemistry Letters

Author:

Jadhav Rajiv A.¹,Ahirrao Vinod K.¹,Patil Rushikesh H.¹,More Kiran B.¹,Tile Anil R.¹,Rane Vipul P.¹,Sonawane Pravin S.¹,Yeole Ravindra D.¹

Affiliation:

1. Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad, 431006, India

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/22297928.2022.2073261

Reference23 articles.

1. https://www.fda.gov/Drugs%20/Guidnce%20ComplianceRegulatoryInformation/Guidances/ucm1/22883.html, 1992.

2. Trivedi, B., Deshpande, P., Ravikumar, T., Gupta, S., Diwakar, S., Pawar, S., Patil, V., Dekhane, D., Patel, M., Bhavsar, S., Mishra, A., Solanki, M., Jafri, M., Bhagwat, S. (2012). US Patent WO 2012/076989 A1. Ketolide compounds.

3. Enantiomeric Separation and Thermodynamic investigation of (R)-5-[1-(4-Nitrobenzylsulfonyloxy)-ethyl]-5-(pyridine-2-yl)- [1,3,4]-thiadiazole, a Key Intermediate of Nafithromycin

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nafithromycin (MIQNAF®): ultramodern lactone ketolide designed to treat community acquired bacterial pneumonia (CABP);Medicinal Chemistry Research;2024-07-23

2. A New Process for the Synthesis of R‐nosylate a Key Intermediate of Nafithromycin;ChemistrySelect;2024-01-02

3. Design and development of efficient synthetic strategies for the chiral synthesis of novel ketolide antibiotic, nafithromycin (WCK 4873);Chemical Papers;2023-02-24